OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

Phase 3 ARANOTE Trial: Darolutamide Plus ADT in Black Patients With Metastatic Hormone-Sensitive Prostate Cancer

10 Oncology Specialists Join OncoDaily Medical Journal’s Editorial Team

Bishal Gyawali: Deescalation Trials do Not Need to be Non Inferiority

Zainab Shinkafi-Bagudu: Hannatu Ayuba Received Recognition at the OncoDaily Yvonne Award Night

Speed and Rigor Are Not in Conflict - Garo Armen

Oncology News, Insights, Stories by OncoDaily

Tedros Adhanom Ghebreyesus
Positive

Tedros Adhanom Ghebreyesus: Zero Deaths From Cervical Cancer Among Vaccinated Woman

Armen Muradyan
Positive

Armen Muradyan Got Re-Elected as the Rector of Yerevan State Medical University

Legend Biotech
Oncolibrary

Legend Biotech Highlights Early LB2501 Data at EHA 2026

European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors

FDA Launches Operation TrialBlazer to Accelerate and Modernize Clinical Development 2026

20 Posts Not To Miss From ESMOGynae26

China Approves Satri-cel, the World’s First CAR-T Therapy for Solid Tumors

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Marco Donia: How Well Do Melanoma Trial Results Predict Routine-Care Outcomes?

Humaid Al-Shamsi: India Recently Achieved a Major Milestone in Cancer Genomics with US FDA

Voices
Gertjan Rasschaert

Gertjan Rasschaert: Attending the Investigator Meeting for the Phase III PROCEADE-CRC-03 Study in Milan

Rachna Khosla: Key Takeaways From BIO 2026 and the Future of Biotech Innovation

Maryam Lustberg: Access and Affordability in Supportive Care Across The Globe

Adam B. Weiner: Can Stockholm3 Outperform PSA for Prostate Cancer Screening?

Vincent Rajkumar: Latest Advances in Myeloma From ASCO, EHA and IMWG 2026

Victor Moreno: Manuel Pedregal Awarded PhD With Highest Distinction

Guillermo Chantada: Addressing Global Challenges in Childhood Cancer at Nostos 2026

FDA Approvals
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Momentum 2026: Accelerating Europe’s Action On Cancer

Cancerfonden – The Swedish Cancer Society

14 Oct
Momentum

VIDAWASI International Medical Congress 2026

VIDAWASI PERÚ

20 Oct
VIDAWASI

3rd Synergies Forum on Cancer: Policy, Research and Funding Strategies

Hellenic Cancer Federation (ELLOK)

29 Jun
3rd Synergies Forum on Cancer

European School of Oncology's Basic Principles in Oncology Course

European School of Oncology (ESO) College

04 Dec
Oncology

ESO's Multidisciplinary Masterclass in Oncology - Autumn Edition

European School of Oncology (ESO) College

06 Nov
Oncology

Immune-oncology
FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC

FDA Approves Sacituzumab Govitecan Plus Pembrolizumab for First-Line PD-L1–Positive TNBC

New Biomarkers for Immunotherapy Success in Metastatic Kidney Cancer

HYPERPROG Study: Hyperprogressive Disease After Immune Checkpoint Inhibitors

GT-20 Trial: Personalized Neoantigen Vaccines for Glioblastoma

Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma

OCEANUS Study: Combination of Radiotherapy and Immunotherapy in Advanced NSCLC

Sipuleucel-T With or Without IL-7 in mCRPC: FDG PET/CT Offers Early Imaging Insights

Gastrointestinal-Oncology
FORTITUDE

Insights From FORTITUDE-101 and FORTITUDE-102: FGFR2b Overexpression in Advanced Gastric and GEJ Cancer

PRODIGE 81-TRIPLET-HCC: Ipilimumab Added to Atezolizumab and Bevacizumab in Advanced HCC

Daraxonrasib at ASCO 2026: The Pancreatic Cancer Moment That Brought the Room to Its Feet

10 Must-Read Posts In GI Oncology This Week

PancreaSure 5-Biomarker Panel for Early and Advanced PDAC Detection

ASCO 2026 Highlights by GI Cancers Alliance: What’s New in Stomach Cancer Care

Practice-Changing and Promising Trials in GI Oncology From ASCO 2026

Breast-Oncology
THP

Can 12 Weeks of THP Be Enough for Some Patients With Early HER2-Positive Breast Cancer?

FDA Approves Palbociclib-Based Maintenance Therapy for HR-Positive, HER2-Positive Metastatic Breast Cancer

European Commission Approves Trodelvy for First-Line Metastatic TNBC in Patients Ineligible for PD-(L)1 Inhibitors

SACI-IO HR+ Trial: 5 Promising Findings in Metastatic Breast Cancer

HER2-Low Status Linked to Shorter PFS With First-Line CDK4/6 Inhibitors in HR-Positive Metastatic Breast Cancer

HER2-Low Subclones Drive T-DXd Resistance in HER2-Heterogeneous Breast Cancer Models

Thermal Ablation Shows Promise in Early-Stage Breast Cancer, but Evidence Remains Limited

Lung-Oncology
ADC

When ADC Toxicity Is Not the Same for Everyone: A Sex-Based Signal in NSCLC

Nature Medicine Retracts NSCLC Immunochemotherapy Trial: 6 Serious Concerns Explained

Can a Routine CT Scan Predict PD-L1 Expression in Metastatic NSCLC?

TROP2 Targeting May Delay EGFR-TKI Resistance in EGFR-Mutant NSCLC

Amivantamab Shows Preclinical Immune-Mediated Activity in Mesothelioma Through Dual EGFR and MET Targeting

Maintenance Pemetrexed May Not Improve Survival With Pembrolizumab in Advanced Nonsquamous NSCLC

ARTIMES AI Volumetry May Improve Response Assessment in Pleural Mesothelioma

OncoDaily TV
Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Episode 17: Global Health Dialogues with Princess Dina and Eman Shannan

Where You Live Shouldn't Dictate Your Cancer Survival: Dr. Benjamin Anderson

Where You Live Shouldn’t Dictate Your Cancer Survival: Dr. Benjamin Anderson

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Investing in Cancer Care: Better Health, Stronger Economies: Herb Riband

Kefah Mokbel

Kefah Mokbel: Can Diet Influence Cancer Risk and Outcomes?

Empowering Oncologists: How to make the most of your fellowship?

Empowering Oncologists: How to make the most of your fellowship?

STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Not To Miss
MASCC-OncoDaily

25 Posts Not To Miss from MASCC 2026

EORTC Announces 2027 Summit for Clinical Cancer Research in Brussels

20 Posts Not To Miss From ESMOGynae26

15 Posts Not To Miss From ESCardioOnco26

Top Growing Medical Universities in Latin America: 2026 Edition by BIGR

15 Posts Not to Miss from ESMO TAT Asia 2026

25 Posts Not To Miss From EHA 2026, Part 3

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
DLBCL NHL

Diffuse Large B-Cell Lymphoma (DLBCL): Molecular Heterogeneity and Progress in Therapy

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): Evolving Biology and Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

CancerWorld

Oncologists
Ting Bao

Ting Bao

Oncologists Location Boston, USA
Lillian Siu

Lillian Siu

Oncologists Location Toronto, Canada
Sarkis Meterissian

Sarkis Meterissian

Oncologists Location Montreal, Canada
Darya Kizub

Darya Kizub

Oncologists Location Houston, USA
Katherine Van Loon

Katherine Van Loon

Oncologists Location San Francisco, USA
Mounir Bachouchi

Mounir Bachouchi

Oncologists Location Rabat, Morocco
Michael Jefford

Michael Jefford

Oncologists Location Melbourne, Australia
Francesco Massari

Francesco Massari

Oncologists Location Bologna, Italy

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

OncoDaily Medical Journal

Lung Cancer

10.69690/ODMJ-001-0626-7958

Evaluation of Intra-Fractional Target Position Variation during Deep Inspiration Breath-Hold (DIBH) Sessions in Lung Stereotactic Body Radiotherapy (SBRT)
Original Research

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports